- Home
- FCEL vs OCGN Comparison
FCEL vs OCGN Comparison
Compare FCEL & OCGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FCEL
- OCGN
- Stock Information
- Founded
- FCEL 1969
- OCGN 2013
- Country
- FCEL United States
- OCGN United States
- Employees
- FCEL N/A
- OCGN N/A
- Industry
- FCEL Industrial Machinery/Components
- OCGN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FCEL Energy
- OCGN Health Care
- Exchange
- FCEL Nasdaq
- OCGN Nasdaq
- Market Cap
- FCEL 201.3M
- OCGN 229.2M
- IPO Year
- FCEL 1992
- OCGN N/A
- Fundamental
- Price
- FCEL $9.59
- OCGN $0.71
- Analyst Decision
- FCEL Hold
- OCGN Strong Buy
- Analyst Count
- FCEL 6
- OCGN 3
- Target Price
- FCEL $22.78
- OCGN $5.67
- AVG Volume (30 Days)
- FCEL 1.3M
- OCGN 6.4M
- Earning Date
- FCEL 03-06-2025
- OCGN 11-08-2024
- Dividend Yield
- FCEL N/A
- OCGN N/A
- EPS Growth
- FCEL N/A
- OCGN N/A
- EPS
- FCEL N/A
- OCGN N/A
- Revenue
- FCEL $112,132,000.00
- OCGN $4,700,000.00
- Revenue This Year
- FCEL $64.70
- OCGN N/A
- Revenue Next Year
- FCEL $3.10
- OCGN N/A
- P/E Ratio
- FCEL N/A
- OCGN N/A
- Revenue Growth
- FCEL N/A
- OCGN N/A
- 52 Week Low
- FCEL $5.45
- OCGN $0.49
- 52 Week High
- FCEL $45.60
- OCGN $2.11
- Technical
- Relative Strength Index (RSI)
- FCEL 44.55
- OCGN 34.87
- Support Level
- FCEL $9.54
- OCGN $0.70
- Resistance Level
- FCEL $13.98
- OCGN $1.00
- Average True Range (ATR)
- FCEL 1.07
- OCGN 0.07
- MACD
- FCEL -0.20
- OCGN -0.01
- Stochastic Oscillator
- FCEL 16.54
- OCGN 4.92
About FCEL FuelCell Energy Inc.
FuelCell Energy Inc is a fuel-cell power company. FuelCell designs manufactures, sells, installs, operates, and services fuel cell products and electrolysis platforms that decarbonize power and produce hydrogen. It serves various industries such as Industrial, Wastewater treatment, Commercial and Hospitality, Data centers and Communications, Education and Healthcare, and others. Geographically, the company generates a majority of its revenue from the United States followed by South Korea.
About OCGN Ocugen Inc.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").